Strengthening societal resilience with Rosalind Biodefense

AI is accelerating progress across biology and the life sciences, creating new opportunities to advance scientific discovery, strengthen public health, and build resilience against biological threats. As these capabilities become more powerful, the institutions working to prevent, detect, and respond to biological threats need equally powerful tools. We believe frontier AI should meaningfully advantage those defenders—and that doing so requires responsible deployment structures and trusted access models that put advanced capabilities in the hands of vetted partners who are building new biodefense applications, tools and initiatives to bolster societal resilience.

That’s why today we’re announcing two new steps to advance defensive acceleration in biology:

Launching Rosalind Biodefense to help trusted developers to build new biodefense and pandemic preparedness capabilities. Apply here.
Expanding trusted access to GPT‑Rosalind for select U.S. government and allied partners supporting public health and biodefense missions. Request access here.

The steps we're taking today are part of a broader strategy to ensure advanced AI meaningfully advantages those working to prevent, detect, and respond to biological threats. That strategy includes equipping defenders through trusted access to advanced AI tools, accelerating the development of medical countermeasures, building earlier warning systems, strengthening diagnostics, preparedness, and response capabilities, and supporting a robust evaluations ecosystem. We will continue to share more about our work across these areas in the coming weeks.